ALDR
Principal Financial Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-23,572
| Closed | -$445K | – | 2336 |
|
2019
Q3 | $445K | Buy |
23,572
+11,311
| +92% | +$214K | ﹤0.01% | 1970 |
|
2019
Q2 | $144K | Buy |
12,261
+1,543
| +14% | +$18.1K | ﹤0.01% | 2167 |
|
2019
Q1 | $146K | Buy |
+10,718
| New | +$146K | ﹤0.01% | 2141 |
|
2018
Q4 | – | Sell |
-20,904
| Closed | -$348K | – | 2362 |
|
2018
Q3 | $348K | Buy |
+20,904
| New | +$348K | ﹤0.01% | 2044 |
|
2018
Q2 | – | Sell |
-12,170
| Closed | -$155K | – | 2328 |
|
2018
Q1 | $155K | Buy |
12,170
+1,090
| +10% | +$13.9K | ﹤0.01% | 2132 |
|
2017
Q4 | $127K | Buy |
+11,080
| New | +$127K | ﹤0.01% | 2171 |
|
2016
Q4 | – | Sell |
-8,336
| Closed | -$273K | – | 2262 |
|
2016
Q3 | $273K | Buy |
8,336
+92
| +1% | +$3.01K | ﹤0.01% | 1967 |
|
2016
Q2 | $206K | Buy |
+8,244
| New | +$206K | ﹤0.01% | 2021 |
|